Detalhe da pesquisa
1.
The methodological and reporting quality of randomized controlled trials of tyrosine kinase inhibitors for advanced differentiated thyroid cancer: Meta-research study.
Head Neck
; 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38344932